Product Description: Biricodar (VX-710) is a modulator of P-glycoprotein and MRP-1; shows effective chemosensitizing activity in multidrug resistant cells.
Applications: Cancer-programmed cell death
Formula: C34H41N3O7
References: [1]Minderman H, et al. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer Res. 2004 Mar 1;10(5):1826-34./[2]Yanagisawa T, et al. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma. Br J Cancer. 1999 Jun;80(8):1190-6./[3]Germann UA, et al. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro. Anticancer Drugs. 1997 Feb;8(2):125-40.
CAS Number: 159997-94-1
Molecular Weight: 603.71
Compound Purity: 99.31
Research Area: Cancer
Solubility: 10 mM in DMSO/DMSO : ≥ 100mg/mL
Target: P-glycoprotein
Deutsch
English
